CB vs TRDA · P/E 14, rev $59.40B vs P/E 12, rev $210.8M
Chubb Ltd (CB) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
CB currently screens at market cap $114.26B and trailing P/E 13.7. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the CB and TRDA stock pages for the full models.
Not investment advice.